Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

TAG72 antibody

Antigen

TAG72

Clonality Monoclonal (B72-3)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human

Application
Alternatives Immunohistochemistry (IHC)
Catalog no. ABIN107225
Quantity 1ml  (100ug/ml approximately)  (Variants)
Price 419.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name TAG-72/CA 72-4
Immunogen BALB/C mice were injected with membrane enriched fraction of a human breast carcinoma liver metastasis.
Format Supernatant
Isotype IgG1 kappa  (Matching secondary antibodies)
Clone B72-3
Specificity This antibody is specific to an oncofetal antigen of >1,000 kD known as tumor associated glycoprotein (TAG-72) or CA 72-4. This antibody defines the mucin carried sialylated-Tn antigen. This antibody stains majority of human adenocarcinomas including colorectal, pancreatic, gastric, ovarian, endometrial, mammary and non-small cell lung cancer.

Application Details

Application Notes Titer/Working Dilution: This antibody may be diluted to a titer of 1:50-1:100 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Formalin fixed paraffin embedded tissue sections require high temperature antigen unmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining. Positive Control: Breast carcinoma. Cellular localization: Cytoplasmic, cell surface
Concentration 100ug/ml approximately
Buffer This antibody is supplied as tissue culture supernatant containing sodium azide as preservative.
Storage Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
Research Area Tags/Labels
Restrictions For Research Use. CE-certified for In Vitro Diagnostics (IVD) Use in the European Union